​

Marker Therapeutics Ownership | Who Owns Marker Therapeutics?

OverviewForecastRevenueFinancialsChart

Marker Therapeutics Ownership Summary

Marker Therapeutics is owned by 0.83% institutional investors, 9.85% insiders, and 89.32% retail investors. Ar asset management is the largest institutional shareholder, holding 0.83% of MRKR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.73% of its assets in Marker Therapeutics shares.

MRKR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMarker Therapeutics0.83%9.85%89.32%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ar asset management73.70K0.83%$229.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ar asset management73.70K0.05%$229.00K

Top Buyers

HolderShares% AssetsChange
Ar asset management73.70K0.05%-

Top Sellers

HolderShares% AssetsChange
Ar asset management73.70K0.05%-

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-73,700--121.08%--100.00%--
Sep 30, 20241-73,7004.24%-130.95%1---
Jun 30, 20241-70,700--125.86%----
Mar 31, 20241-70,700--123.79%----
Dec 31, 20231-70,700--124.07%--100.00%--

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv185.70K1.73%32.22K
Vanguard US Total Market Shares ETF153.47K1.43%-
Vanguard Institutional Extnd Mkt Idx Tr87.14K0.81%-
Fidelity Extended Market Index38.53K0.36%-245.00
WEALTHGATE Biotech Aggressive Fund I25.44K0.29%-
Vifag 2002 SICAV30.00K0.28%-
DFA US Small Cap I15.90K0.15%-
iShares Micro-Cap ETF13.96K0.13%-
Fidelity Total Market Index12.81K0.12%-
WEALTHGATE Biotech Fund Inst9.51K0.09%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 23, 2024ELMS STEVE-Buy$35.47K
Dec 23, 2024New Enterprise Associates 16, L.P.-Buy$1.77M
Mar 16, 2021Eansor Norman David-Buy$249.99K
May 18, 2021Wasserman Frederick Gerald-Buy$24.10K
Mar 16, 2021Walker Paul Edward-Buy$10.00M

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q42-
2023 Q2--
2023 Q1--
2022 Q2--

MRKR Ownership FAQ

Who Owns Marker Therapeutics?

Marker Therapeutics shareholders are primarily institutional investors at 0.83%, followed by 9.85% insiders and 89.32% retail investors. The average institutional ownership in Marker Therapeutics's industry, Biotech Stocks , is 68.48%, which Marker Therapeutics falls below.

Does Blackrock own Marker Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Marker Therapeutics.

Who is Marker Therapeutics’s biggest shareholder by percentage of total assets invested?

Ar asset management is Marker Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 73.7K Marker Therapeutics shares, valued at 229K$.

Who is the top mutual fund holder of Marker Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Marker Therapeutics shares, with 1.73% of its total shares outstanding invested in 185.7K Marker Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools